Health Canada inspection
Novartis Pharmaceuticals Canada Inc: Health Canada inspection of Apr 2, 2026
Health Canada · GVP · rating C
Key facts
| Establishment | Novartis Pharmaceuticals Canada Inc |
|---|---|
| City | Montreal |
| Province | Quebec |
| Country | Canada |
| Program | GVP |
| Start date | Mar 31, 2026 |
| End date | Apr 2, 2026 |
| Rating | C |
| Rating description | Compliant |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.
Source: Health Canada, Drug and Health Product Inspections. Contains information licensed under the Open Government Licence – Canada · Source date: